Authors

• Azza El‐Sayed Mansy
• Ahmed G. Abd Elhameed (ORCID: https://orcid.org/0000-0002-3899-6865)
• Muhammed M. Salahuddin (ORCID: https://orcid.org/0000-0001-7464-1706)
• Sherif Mourad (ORCID: https://orcid.org/0000-0001-6399-2279)
• Eslam Habba (ORCID: https://orcid.org/0000-0003-3164-4936)
• Eman Hamza (ORCID: https://orcid.org/0000-0001-9798-842X)
• Marwa Kamal (ORCID: https://orcid.org/0000-0002-3261-0327)
• Manal A. Hamouda
• Tarek I. Ahmed
• Furqan M. Abdulelah (ORCID: https://orcid.org/0000-0002-0885-7848)
• Mohannad O Khrieba
• Hayam Ali AlRasheed (ORCID: https://orcid.org/0009-0002-6186-848X)
• Nora Elshorbagi
• Nada A Alsaleh

Institutions

• Princess Nourah bint Abdulrahman University (SA)
• Damietta University (EG)
• Sinai University (EG)
• Mansoura University (EG)
• Tanta University (EG)
• Imam Mohammad ibn Saud Islamic University (SA)
• Nahrain University (IQ)
• Menoufia University (EG)
• Fayoum University (EG)

Publication Details

Journal

Frontiers in Pharmacology

Published

2025-10-29

DOI

https://doi.org/10.3389/fphar.2025.1690513

Primary Topic

Inflammatory Bowel Disease

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Princess Nourah Bint Abdulrahman University